Principia Biopharma Inc (PRNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,689 | -32,499 | -53,792 | -28,868 | -6,572 |
| Depreciation Amortization | 577 | 155 | 269 | 112 | -127 |
| Accounts payable and accrued liabilities | -610 | -227 | -2,082 | -1,609 | -52 |
| Other Working Capital | -44,723 | 352 | -880 | -991 | -1,686 |
| Other Operating Activity | 12,019 | 4,747 | 13,939 | 10,489 | 5,953 |
| Operating Cash Flow | $-54,426 | $-27,472 | $-42,546 | $-20,867 | $-2,484 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 183,207 | 47,016 | -180,452 | 15,773 | 9,885 |
| PPE Investments | -325 | -178 | -2,171 | -2,154 | -1,913 |
| Investing Cash Flow | $182,882 | $46,838 | $-182,623 | $13,619 | $7,972 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,493 | 524 | 230,135 | 2,088 | 1,014 |
| Financing Cash Flow | $2,493 | $524 | $230,135 | $2,088 | $1,014 |
| Beginning Cash Position | 40,104 | 40,104 | 35,138 | 35,138 | 35,138 |
| End Cash Position | 171,053 | 59,994 | 40,104 | 29,978 | 41,640 |
| Net Cash Flow | $130,949 | $19,890 | $4,966 | $-5,160 | $6,502 |
| Free Cash Flow | |||||
| Operating Cash Flow | -54,426 | -27,472 | -42,546 | -20,867 | -2,484 |
| Capital Expenditure | -325 | -178 | -2,171 | -2,154 | -1,913 |
| Free Cash Flow | -54,751 | -27,650 | -44,717 | -23,021 | -4,397 |